The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial
This study was carried out to investigate the effects of chromium intake on glycemic control, markers of cardio-metabolic risk, and oxidative stress in infertile polycystic ovary syndrome (PCOS) women candidate for in vitro fertilization (IVF). This randomized double-blind, placebo-controlled trial was done among 40 subjects with infertile PCOS candidate for IVF, aged 18–40 years old. Individuals were randomly allocated into two groups to take either 200 μg/day of chromium (n = 20) or placebo (n = 20) for 8 weeks. Biochemical parameters were assessed at baseline and at end-of-trial. Compared with the placebo, taking chromium supplements led to significant reductions in fasting plasma glucose (− 2.3 ± 5.7 vs. + 0.9 ± 3.1 mg/dL, P = 0.03), insulin levels (− 1.4 ± 2.1 vs. + 0.4 ± 1.7 μIU/mL, P = 0.004), homeostatic model of assessment for insulin resistance (− 0.3 ± 0.5 vs. + 0.1 ± 0.4, P = 0.005), and a significant increase in quantitative insulin sensitivity check index (+ 0.004 ± 0.008 vs. − 0.001 ± 0.008, P = 0.03). In addition, chromium supplementation significantly decreased serum triglycerides (− 19.2 ± 33.8 vs. + 8.3 ± 21.7 mg/dL, P = 0.004), VLDL- (− 3.8 ± 6.8 vs. + 1.7 ± 4.3 mg/dL, P = 0.004) and total cholesterol concentrations (− 15.3 ± 26.2 vs. − 0.6 ± 15.9 mg/dL, P = 0.03) compared with the placebo. Additionally, taking chromium supplements was associated with a significant increase in plasma total antioxidant capacity (+ 153.9 ± 46.1 vs. − 7.8 ± 43.9 mmol/L, P < 0.001) and a significant reduction in malondialdehyde values (−0.3 ± 0.3 vs. + 0.1 ± 0.2 μmol/L, P = 0.001) compared with the placebo. Overall, our study supported that chromium administration for 8 weeks to infertile PCOS women candidate for IVF had beneficial impacts on glycemic control, few variables of cardio-metabolic risk, and oxidative stress.
KeywordsChromium supplementation Glycemic control Cardio-metabolic Polycystic ovary syndrome
ZA helped inthe conception, design, and statistical analysis of the manuscript. MJ, SZ, MA-S, MK, AM, and VO contributed in data collection and manuscript drafting. ZA supervised the study.
This study was supported by a grant from the Vice-chancellor for Research, Arak University of Medical Sciences, Arak, Iran.
Compliance with Ethical Standards
Conflicts of Interest
The authors declare that they have no conflict of interest.
- 2.Hwang JL, Seow KM, Lin YH, Huang LW, Hsieh BC, Tsai YL, Wu GJ, Huang SC, Chen CY, Chen PH, Tzeng CR (2004) Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study. Hum Reprod 19(9):1993–2000. https://doi.org/10.1093/humrep/deh375 CrossRefPubMedGoogle Scholar
- 3.MacDougall MJ, Tan SL, Balen A, Jacobs HS (1993) A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 8(2):233–237. https://doi.org/10.1093/oxfordjournals.humrep.a138029 CrossRefPubMedGoogle Scholar
- 7.Vlaisavljevic V, Kovac V, Sajko MC (2009) Impact of insulin resistance on the developmental potential of immature oocytes retrieved from human chorionic gonadotropin-primed women with polycystic ovary syndrome undergoing in vitro maturation. Fertil Steril 91(3):957–959. https://doi.org/10.1016/j.fertnstert.2007.12.062 CrossRefPubMedGoogle Scholar
- 8.Ingle ME, Bloom MS, Parsons PJ, Steuerwald AJ, Kruger P, Fujimoto VY (2017) Associations between IVF outcomes and essential trace elements measured in follicular fluid and urine: a pilot study. J Assist Reprod Genet 34(2):253–261. https://doi.org/10.1007/s10815-016-0853-7 CrossRefPubMedGoogle Scholar
- 14.Lucidi RS, Thyer AC, Easton CA, Holden AE, Schenken RS, Brzyski RG (2005) Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril 84(6):1755–1757. https://doi.org/10.1016/j.fertnstert.2005.06.028 CrossRefPubMedGoogle Scholar
- 15.Sahin K, Tuzcu M, Orhan C, Sahin N, Kucuk O, Ozercan IH, Juturu V, Komorowski JR (2013) Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin. Br J Nutr 110(02):197–205. https://doi.org/10.1017/S0007114512004850 CrossRefPubMedGoogle Scholar
- 16.Martino F, Puddu PE, Pannarale G, Colantoni C, Martino E, Niglio T, Zanoni C, Barilla F (2013) Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan. Atherosclerosis 228(1):198–202. https://doi.org/10.1016/j.atherosclerosis.2013.02.005 CrossRefPubMedGoogle Scholar
- 17.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25Google Scholar
- 18.Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT (2013) Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 36(4):845–853. https://doi.org/10.2337/dc12-0840 CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A (2015) Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr 34(4):586–592. https://doi.org/10.1016/j.clnu.2014.09.015 CrossRefPubMedGoogle Scholar
- 24.Foroozanfard F, Jamilian M, Bahmani F, Talaee R, Talaee N, Hashemi T, Nasri K, Asemi Z, Esmaillzadeh A (2015) Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol 83(6):888–894. https://doi.org/10.1111/cen.12840 CrossRefGoogle Scholar
- 28.Saiyed ZM, Lugo JP (2016) Impact of chromium dinicocysteinate supplementation on inflammation, oxidative stress, and insulin resistance in type 2 diabetic subjects: an exploratory analysis of a randomized, double-blind, placebo-controlled study. Food Nutr Res 60(1):31762. https://doi.org/10.3402/fnr.v60.31762 CrossRefPubMedGoogle Scholar
- 31.Masharani U, Gjerde C, McCoy S, Maddux BA, Hessler D, Goldfine ID, Youngren JF (2012) Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity. BMC Endocr Disord 12(1):31. https://doi.org/10.1186/1472-6823-12-31 CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Huang H, Chen G, Dong Y, Zhu Y, Chen H (2017) Chromium supplementation for adjuvant treatment of type 2 diabetes mellitus: results from a pooled analysis. Mol Nutr Food Res. https://doi.org/10.1002/mnfr.201700438. [Epub ahead of print]
- 39.Paiva AN, Lima JG, Medeiros AC, Figueiredo HA, Andrade RL, Ururahy MA, Rezende AA, Brandao-Neto J, Almeida M (2015) Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: a randomized clinical study. J Trace Elem Med Biol 32:66–72. https://doi.org/10.1016/j.jtemb.2015.05.006 CrossRefPubMedGoogle Scholar
- 40.Li S, Chu Q, Ma J, Sun Y, Tao T, Huang R, Liao Y, Yue J, Zheng J, Wang L, Xue X, Zhu M, Kang X, Yin H, Liu W (2017) Discovery of novel lipid profiles in pcos: do insulin and androgen oppositely regulate bioactive lipid production? J Clin Endocrinol Metab 102(3):810–821. https://doi.org/10.1210/jc.2016-2692 PubMedGoogle Scholar
- 43.Xu X, Liu L, Long SF, Piao XS, Ward TL, Ji F (2017) Effects of chromium methionine supplementation with different sources of zinc on growth performance, carcass traits, meat quality, serum metabolites, endocrine parameters, and the antioxidant status in growing-finishing pigs. Biol Trace Elem Res 179(1):70–78. https://doi.org/10.1007/s12011-017-0935-0 CrossRefPubMedGoogle Scholar
- 44.Tian YY, Zhang LY, Dong B, Cao J, Xue JX, Gong LM (2014) Effects of chromium methionine supplementation on growth performance, serum metabolites, endocrine parameters, antioxidant status, and immune traits in growing pigs. Biol Trace Elem Res 162(1-3):134–141. https://doi.org/10.1007/s12011-014-0147-9 CrossRefPubMedGoogle Scholar
- 45.Jamilian M, Bahmani F, Siavashani MA, Mazloomi M, Asemi Z, Esmaillzadeh A (2016) The effects of chromium supplementation on endocrine profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res 172(1):72–78. https://doi.org/10.1007/s12011-015-0570-6 CrossRefPubMedGoogle Scholar